Vanguard Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131M | Buy |
|
|||||
|
2025
Q1 | $82.8M | Buy |
|
|||||
|
2024
Q4 | $64.2M | Buy |
|
|||||
|
2024
Q3 | $54.5M | Buy |
|
|||||
|
2024
Q2 | $37M | Sell |
|
|||||
|
2024
Q1 | $41.3M | Buy |
|
|||||
|
2023
Q4 | $62.6M | Buy |
|
|||||
|
2023
Q3 | $66.8M | Buy |
|
|||||
|
2023
Q2 | $80.9M | Buy |
|
|||||
|
2023
Q1 | $106M | Buy |
|
|||||
|
2022
Q4 | $90.1M | Buy |
|
|||||
|
2022
Q3 | $83.1M | Buy |
|
|||||
|
2022
Q2 | $93.7M | Buy |
|
|||||
|
2022
Q1 | $154M | Buy |
|
|||||
|
2021
Q4 | $310M | Buy |
|
|||||
|
2021
Q3 | $374M | Buy |
|
|||||
|
2021
Q2 | $416M | Buy |
|
|||||
|
2021
Q1 | $403M | Buy |
|
|||||
|
2020
Q4 | $571M | Buy |
|
|||||
|
2020
Q3 | $344M | Buy |
|
|||||
|
2020
Q2 | $273M | Buy |
|
|||||
|
2020
Q1 | $124M | Buy |
|
|||||
|
2019
Q4 | $47.3M | Buy |
|
|||||
|
2019
Q3 | $46.2M | Buy |
|
|||||
|
2019
Q2 | $9.66M | Buy |
|